Specific features of peripheral blood lymphocyte phenotype in women with recurrent miscarriage


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study peripheral blood lymphocyte subpopulations in women with recurrent miscarriage of alloimmune genesis, by estimating the counts of natural killer cells with a different phenotype, CD200 molecule, and natural regulatory T cells. Subject and methods. The phenotype of peripheral blood lymphocytes was determined on 18-20 days of the menstrual cycle in 70 patients with recurrent miscarriage after ruling out its known causes and in 15 fertile healthy women in a control group. Results. The married couples with recurrent miscarriage of alloimmune genesis constitute 21.9% of all married couples with recurrent pregnancy losses. The women with recurrent miscarriage had significantly higher levels of cells with the phenotype CD3 -CD8+, CD56+, CD3+CD56,16 +, CD3 -CD56,16 +, SCD56,16 +, CD5+CD19+, CD200 v, significantly lower counts of cells with the phenotype CD4 +CD25 highCD127 low/-, and a significantly higher ratio of cells with the phenotype CD20(+ and CD4+CD25 hig hCD127 low/-. Conclusion. The patients with recurrent miscarriage of alloimmune genesis versus the fertile women commonly show significant changes in the lymphocyte subpopulations of natural killer cells with a different phenotype and in the count of natural regulatory T cells and lymphocytes with the phenotype CD200+. The potential role of these changes in the diagnosis and monitoring of the efficiency of performed therapy is to be further investigated.

Full Text

Restricted Access

About the authors

Lyubov V. Krechetova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: l_krechetova@oparina4.ru
PhD in medical sciences, Head of Laboratory of Clinical Immunology

Nelly A. Khachatryan

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: nellyl986@mail.ru
Graduate student, Department of Pregnancy Loss Prevention and Therapy

Nana K. Tetruashvili

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: tetrauly@mail.ru
MD, Head of the Department of Pregnancy Loss Prevention and Therapy

Valentina V. Vtorushina

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: vtorushina@inbox.ru
PhD in medical sciences, doctor of laboratory diagnostics in Laboratory of Clinical Immunology

Elena Olegovna Stepanova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: elena2404.07@mail.ru
Junior researcher, Laboratory of Clinical Immunology

Marina A. Nikolaeva

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: nikolaeva_ma@mail.ru
Doctor of Science, Leading researcher, Laboratory of Clinical Immunology

Gennady T. Sukhikh

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: gtsukhikh@mail.ru
MD, Professor, Academician of Russian Academy of Sciences, Director

References

  1. Carp Howard J.A., ed. Reccurent pregnancy loss: causes, controversies and treatment. Informa UK ltd.; 2007. 290 p.
  2. Farquharson R.G., Mary D., Stephenson M.D., eds. Early pregnancy. Cambridge University Press; 2012.
  3. Chong P.J., Matzner W.L., Ching W.T. Benefit of leukocyte immunizations? Fertil. Steril. 1993; 59(1): 247-9.
  4. Chong P.J., Matzner W.L., Ching W.T. Controversy about immunotherapy. Fertil. Steril. 1993; 59(5): 1138-9.
  5. Lee S.K., Na B.J., Kim J.Y., Hur S.E., Lee M., Gilman-Sachs A., Kwak-Kim J. Determination of clinical cellular immune markers in women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 2013; 70(5): 398-411. doi: 10.1111/ aji.12137.
  6. Chaouat G. Inflammation, NK cells and implantation: friend and foe (the good, the bad and the ugly?): replacing placental viviparity in an evolutionary perspective. J. Reprod. Immunol. 2013; 97(1): 2-13.
  7. Williams Z. Inducing tolerance to pregnancy. N. Engl. J. Med. 2012; 367(12): 1159-61.
  8. Zenclussen A.C. Regulatory T cells in pregnancy. Springer Semin. Immunopathol. 2006; 28: 31-9.
  9. Saito S., Shima T., Nakashima A., Shiozaki A., Ito M., Sasaki Y. What is the role of regulatory T cells in the success of implantation and early pregnancy? J. Assist. Reprod. Genet. 2007; 24(9): 379-86.
  10. Vacca P., Cantoni C., Vitale M., Prato C., Canegallo F., Fenoglio D. et al. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. USA. 2010; 107(26): 11918-23.
  11. Trabanelli S., Ocadlikova D., Evangelisti C., Parisi S., Curti A. Induction of regulatory T cells by dendritic cells through indoleamine 2,3-dioxygenase: A Potent Mechanism of Acquired Peripheral tolerance. Curr. Med. Chem. 2011; 18(15): 2234-9.
  12. Clark D.A., Wong K., Banwatt D., Chen Z., Liu J., Lee L. et al. CD200-dependent and nonCD200-dependent pathways of NK cell suppression by human IVIG. J. Assist. Reprod. Genet. 2008; 25(2-3): 67-72.
  13. Clark D.A. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am. J. Reprod. Immunol. 2009; 61(1): 75-84.
  14. Saito S., Nakashima A., Shima T. Future directions of studies for recurrent miscarriage associated with immune etiologies. J. Reprod. Immunol. 2011; 90(1): 91-5.
  15. Raghupathy R. The immune system in pregnancy: friend or foe? Kuwait Med. J. 2009; 41(2): 93-102.
  16. Hui Yang, Lihua Qiu, Guangjie Chen, Zi Ye, Caijun Lu, Qide Lin. Proportional change of CD4+CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil. Steril. 2008; 89(3): 656-60.
  17. Сидельникова В.М., Сухих Г.Т. Невынашивание беременности. Руководство для практикующих врачей. М.: МИА; 2011. 516 с. [Sidelnikova V.M., Sukhikh G.T. Miscarriage. Guidelines for clinicians. M.: MIA; 2011. 516 p.]
  18. Посисеева Л.В., Малышкина А.И., Бойко Е.Л., Сотникова Н.Ю., Перетятко Л.П., Фетисова И.Н. Реабилитация репродуктивного здоровья супружеских пар с невынашиванием беременности. Иваново: «Изд-во «Иваново»; 2008. 240 с. [Posiseyeva L.V., Malyshkina A.I., Boyko E.L., Sotnikova N.Yu., Peretyatko L.P., Fetisova I.N. Rehabilitation of the reproductive health of couples with recurrent miscarriages. Ivanovo: “Publishing house Ivanovo”; 2008. 240 p.]
  19. Agrawal S., Pandey M.K., Mandai S., Mishra L., Agarwal S. Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth. 2002; 2(1): 6.
  20. Zenclussen A.C., Gelof K., Zenclussen M.L., Ritter T., Kotsch K., Leber J., Volk H.D. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+ CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 2005; 166: 811-22.
  21. Shou Z., Xu Y., Xiao H., Zhou Q., Cai J., Yang Y. et al. The effect of pregnancy on paternal skin allograft survival. Sci. China C Life Sci. 2009; 52(11): 1011-5.
  22. Saito S., Sasaki Y., Sakai M. CD4+CD25+high regulatory T cells in human pregnancy. J. Reprod. Immunol. 2005; 65(2): 111-20.
  23. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004; 112(1): 38-43.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies